A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction.
暂无分享,去创建一个
[1] Guy Salama,et al. Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.
[2] Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. , 2005, Biochemical and biophysical research communications.
[3] C. Long,et al. Yin Yang 1 represses α-myosin heavy chain gene expression in pathologic cardiac hypertrophy , 2004 .
[4] B. Harrison,et al. The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression , 2004, Molecular and Cellular Biology.
[5] M. Crow,et al. Sustained &bgr;1-Adrenergic Stimulation Modulates Cardiac Contractility by Ca2+/Calmodulin Kinase Signaling Pathway , 2004 .
[6] J. Brown,et al. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. , 2004, Cardiovascular research.
[7] M. Anderson. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.
[8] R. Lefkowitz,et al. Myocardial β-adrenergic receptor signaling in vivo: insights from transgenic mice , 1996, Journal of Molecular Medicine.
[9] M. Crow,et al. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. , 2004, Circulation research.
[10] C. Long,et al. Adrenergic hormones and control of cardiac myocyte growth , 2004, Molecular and Cellular Biochemistry.
[11] M. Prasad,et al. Enhanced membrane protein kinase C activity in myocardial ischemia , 2004, Basic Research in Cardiology.
[12] T. Eschenhagen,et al. Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase. , 2003, Cardiovascular research.
[13] C. Long,et al. Yin Yang 1 Is Increased in Human Heart Failure and Represses the Activity of the Human α-Myosin Heavy Chain Promoter* , 2003, Journal of Biological Chemistry.
[14] O. Brodde,et al. Role of β1- and β2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[15] A. Dart,et al. Altered calcium transient and development of hypertrophy in β2‐adrenoceptor overexpressing mice with and without pressure overload , 2003, European journal of heart failure.
[16] B. Kobilka,et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.
[17] O. Brodde,et al. Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes. , 2003, Naunyn-Schmiedeberg's archives of pharmacology.
[18] G. Wallukat,et al. The β-Adrenergic Receptors , 2002, Herz.
[19] R. Quaife,et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. , 2002, The New England journal of medicine.
[20] Michael R. Bristow,et al. Regulation of Thyroid Hormone Receptor Isoforms in Physiological and Pathological Cardiac Hypertrophy , 2001, Circulation research.
[21] K. McDonald,et al. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. , 2001, American journal of physiology. Heart and circulatory physiology.
[22] Y. Kihara,et al. Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure , 2001, Circulation.
[23] Rick B. Vega,et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Vatner,et al. β-adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart , 2001 .
[25] S. Vatner,et al. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. , 2001, Journal of molecular and cellular cardiology.
[26] Y. Zou,et al. Ca2+/Calmodulin-dependent Kinase II and Calcineurin Play Critical Roles in Endothelin-1-induced Cardiomyocyte Hypertrophy* , 2000, The Journal of Biological Chemistry.
[27] R. Devereux,et al. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. , 1999, Hypertension research : official journal of the Japanese Society of Hypertension.
[28] H. Cantiello,et al. Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Leinwand,et al. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. , 1998, Circulation research.
[30] G. Jennings,et al. Adrenergic nervous system in heart failure. , 1997, The American journal of cardiology.
[31] M. Bristow. Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.
[32] M. Bristow,et al. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.
[33] C. Long,et al. Interleukin-1β Is a Negative Transcriptional Regulator of α1-Adrenergic Induced Gene Expression in Cultured Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.
[34] A. Clerk,et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. , 1996, The Biochemical journal.
[35] C. Long,et al. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. , 1996, The Journal of biological chemistry.
[36] R. Lefkowitz,et al. Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice. , 1996, Journal of molecular medicine.
[37] E. Lakatta,et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. , 1995, The American journal of physiology.
[38] B. Wollnik,et al. Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth. , 1995, European heart journal.
[39] C. Glembotski,et al. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin. , 1994, The Journal of biological chemistry.
[40] C. Long,et al. Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. , 1993, Journal of molecular and cellular cardiology.
[41] S. Goldstein,et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. , 1992, Journal of the American College of Cardiology.
[42] C. Long,et al. Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy. , 1992, Basic research in cardiology.
[43] C. Long,et al. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. , 1991, Cell regulation.
[44] D. Atlas,et al. The Metabotropic Glutamate Receptors , 1994, The Receptors.
[45] P. Simpson,et al. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. , 1990, The Journal of clinical investigation.
[46] P. Simpson,et al. Myocyte Hypertrophy in Neonatal Rat Heart Cultures and Its Regulation by Serum and by Catecholamines , 1982, Circulation research.
[47] P. Simpson,et al. Differentiation of Rat Myocytes in Single Cell Cultures with and without Proliferating Nonmyocardial Cells: Cross‐Striations, infrastructure, and Chronotropic Response to Isoproterenol , 1982, Circulation research.
[48] B. Swynghedauw,et al. Myosin isoenzyme redistribution in chronic heart overload , 1979, Nature.
[49] B MAYNE,et al. On aortic regurgitation , 1953, Irish journal of medical science.